NFA
RARE icon

Nationwide Fund Advisors’s Ultragenyx Pharmaceutical RARE Stock Holding History

Nationwide Fund Advisors’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-57,314
Closed -$3.05M – 1616
2017
Q3 		$3.05M Sell
57,314
-2,709
-5% -$161K 0.01% 1262
2017
Q2 		$3.73M Buy
60,023
+11,685
+24% +$704K 0.02% 1151
2017
Q1 		$3.28M Sell
48,338
-1,049
-2% -$79.9K 0.01% 1190
2016
Q4 		$3.47M Buy
49,387
+187
+0.4% +$13.3K 0.01% 1171
2016
Q3 		$3.49M Sell
49,200
-28,410
-37% -$1.81M 0.01% 1152
2016
Q2 		$3.8M Sell
77,610
-9,761
-11% -$631K 0.02% 1076
2016
Q1 		$5.55M Buy
87,371
+6,066
+7% +$397K 0.02% 881
2015
Q4 		$9.12M Sell
81,305
-2,105
-3% -$210K 0.04% 613
2015
Q3 		$8.03M Buy
83,410
+9,291
+13% +$1.06M 0.04% 632
2015
Q2 		$7.59M Buy
74,119
+16,069
+28% +$1.25M 0.03% 729
2015
Q1 		$3.6M Buy
58,050
+5,351
+10% +$297K 0.01% 1141
2014
Q4 		$2.31M Buy
52,699
+6,152
+13% +$282K 0.01% 1340
2014
Q3 		$2.63M Buy
46,547
+28,992
+165% +$1.46M 0.01% 1279
2014
Q2 		$788K Buy
17,555
+7,422
+73% +$306K ﹤0.01% 2021
2014
Q1 		$495K Buy
+10,133
New +$522K ﹤0.01% 2066

Other funds holding RARE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Nationwide Fund Advisors's RARE Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Ultragenyx Pharmaceutical (RARE) in Q4 2017, closing a stake of 57,314 shares — an estimated $3.05M sold.

Nationwide Fund Advisors first reported a position in RARE in Q1 2014 and held it in 15 quarters. The position peaked at $9.12M in Q4 2015. 163 funds tracked by Wall St. Rank hold RARE as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Ultragenyx Pharmaceutical position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 57,314 Ultragenyx Pharmaceutical shares in Q4 2017, an estimated $3.05M.
  • Nationwide Fund Advisors first reported a position in Ultragenyx Pharmaceutical in Q1 2014 and held it in 15 quarters.
  • Nationwide Fund Advisors's Ultragenyx Pharmaceutical position peaked at $9.12M in Q4 2015.
  • 163 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.